Pan-Bcl-2 inhibitor, GX15-070 (obatoclax), decreases human T regulatory lymphocytes while preserving effector T lymphocytes: a rationale for its use in combination immunotherapy

Pan-Bcl-2 inhibitor, GX15-070 (obatoclax), decreases human T regulatory lymphocytes while preserving effector T lymphocytes: a rationale for its use in combination immunotherapy

Item
http://www.wikidata.org/entity/Q34004454
Minireview: Regulatory T Cells and Ovarian Cancer.Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseasesPotential utility of the pan-Bcl-2 inhibitor GX15-070 (obatoclax) in cancer immunotherapy.Obatoclax regulates the proliferation and fusion of osteoclast precursors through the inhibition of ERK activation by RANKLKilling Two Cells with One Stone: Pharmacologic BCL-2 Family Targeting for Cancer Cell Death and Immune Modulation.Emerging roles of regulatory T cells in tumour progression and metastasis.Therapeutic targeting of Bcl-2 family for treatment of B-cell malignancies.Perenosins: a new class of anion transporter with anti-cancer activity.Analyses of functions of an anti-PD-L1/TGFβR2 bispecific fusion protein (M7824).Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung.BH3 mimetics induce apoptosis independent of DRP-1 in melanoma
P2860

Pan-Bcl-2 inhibitor, GX15-070 (obatoclax), decreases human T regulatory lymphocytes while preserving effector T lymphocytes: a rationale for its use in combination immunotherapy

Item
http://www.wikidata.org/entity/Q34004454
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pan-Bcl-2 inhibitor, GX15-070 ...... e in combination immunotherapy
@ast
Pan-Bcl-2 inhibitor, GX15-070 ...... e in combination immunotherapy
@en
Pan-Bcl-2 inhibitor, GX15-070 ...... e in combination immunotherapy
@nl
type
label
Pan-Bcl-2 inhibitor, GX15-070 ...... e in combination immunotherapy
@ast
Pan-Bcl-2 inhibitor, GX15-070 ...... e in combination immunotherapy
@en
Pan-Bcl-2 inhibitor, GX15-070 ...... e in combination immunotherapy
@nl
prefLabel
Pan-Bcl-2 inhibitor, GX15-070 ...... e in combination immunotherapy
@ast
Pan-Bcl-2 inhibitor, GX15-070 ...... e in combination immunotherapy
@en
Pan-Bcl-2 inhibitor, GX15-070 ...... e in combination immunotherapy
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Pan-Bcl-2 inhibitor, GX15-070 ...... e in combination immunotherapy
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932